OpenVSafe by OpenVAERS
Search V-safe

28P-16906-02644

2 vaccinations 2 coded responses 7 check-ins 2 free-text entries 0 call cases
Sex
Female
Age at first dose
31-35
ZIP prefix
191 / PA
Registered
2021-03-26
Relationship
Self
Race
Black or African American
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-03-05
    Dose 1 — Pfizer-BioNTech
  2. 2021-03-26
    Registered in v-safe
  3. 2021-03-26
    Dose 2 — Pfizer-BioNTech
  4. 2021-03-26
    Health check-in — day 0, dose 2
    Feeling: Fair · Site: Pain · Chills, Fatigue or tiredness
    Adult check-in
  5. 2021-03-27
    Health check-in — days 1–6 daily, dose 2
    Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to do your normal daily activities
    Adult check-in
  6. 2021-03-28
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymphadenopathy — Feeling: Poor · Site: Pain · Fever · Headache, Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Swollen glands
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  7. 2021-03-29
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · Fatigue or tiredness
    Adult check-in
  8. 2021-03-30
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  9. 2021-09-24
    Survey response — 6 months, dose 2
    MedDRA: Pregnancy — Feeling: Good
    Free text: Pregnant
    MedDRA releases: 2024-11 · check-in free text available
  10. 2022-03-26
    Health check-in — 12 months, dose 2
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-03-05Pfizer-BioNTech
22021-03-26Pfizer-BioNTech

Free text

Release 6 — days 1–6 daily, dose 2

2021-03-28

Systemic reaction (other): Swollen glands

Release 9 — 6 months, dose 2

2021-09-24

Symptoms: Pregnant

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDPregnancy · · ✓
SROLymphadenopathy ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release